Unlock stock picks and a broker-level newsfeed that powers Wall Street.

NasdaqGS - Nasdaq Real Time Price USD

Clever Leaves Holdings Inc. (CLVRW)

Compare
0.0250
0.0000
(0.00%)
At close: July 18 at 10:39:24 AM EDT
Loading Chart for CLVRW
  • Previous Close 0.0250
  • Open 0.0250
  • Bid 0.0100 x --
  • Ask 0.0150 x --
  • Day's Range 0.0250 - 0.0250
  • 52 Week Range 0.0010 - 0.0500
  • Volume 1,100
  • Avg. Volume 0
  • Market Cap (intraday) --
  • Beta (5Y Monthly) 3,111.22
  • PE Ratio (TTM) --
  • EPS (TTM) --
  • Earnings Date --
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

Clever Leaves Holdings Inc. operates in the botanical cannabinoid and nutraceutical industries. The company operates through two segments, Cannabinoid and Non-Cannabinoid. The Cannabinoid segment cultivates, extracts, manufactures, commercializes, and distributes cannabinoid products comprising cannabis flowers, cannabidiol isolates, full spectrum and standardized extracts, and dry smokable flowers internationally. The Non-Cannabinoid segment formulates, manufactures, markets, sells, distributes, and commercializes nutraceutical and other natural remedies, wellness products, detoxification products, and nutritional and dietary supplements for mass retailers, specialty and health retailers, and distributors in the United States. It also produces extracted products, including isolates, crude oil extracts, and oral solutions; and tetrahydrocannabinol flowers. The company serves retail distributors, pharmaceutical and cannabis companies, and pharmacies. Clever Leaves Holdings Inc. was founded in 2017 and is based in Tocancipá, Colombia.

cleverleaves.com

296

Full Time Employees

--

Fiscal Year Ends

Recent News: CLVRW

View More

Compare To: CLVRW

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: CLVRW

View More

Valuation Measures

Annual
As of
  • Market Cap

    --

  • Enterprise Value

    --

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    --

  • Price/Book (mrq)

    --

  • Enterprise Value/Revenue

    --

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -102.77%

  • Return on Assets (ttm)

    -23.39%

  • Return on Equity (ttm)

    -61.27%

  • Revenue (ttm)

    17.42M

  • Net Income Avi to Common (ttm)

    -19.8M

  • Diluted EPS (ttm)

    --

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    6.83M

  • Total Debt/Equity (mrq)

    8.62%

  • Levered Free Cash Flow (ttm)

    -2.25M

Research Analysis: CLVRW

View More

Company Insights: CLVRW

Research Reports: CLVRW

View More